Literature DB >> 17669760

Ideal timing of surgical repair of isolated complete atrioventricular septal defect.

Mariko Kobayashi1, Yukihiro Takahashi, Makoto Ando.   

Abstract

The ideal timing and optimal management of surgical repair for isolated complete atrioventricular septal defect (CAVSD) still remains controversial. To determine outcomes after the surgical repair of CAVSD, we reviewed 100 consecutive patients who underwent complete repair at our institute between January 1992 and August 2003. Among these 100 patients, 52 were female and 73 had Down's syndrome. Twelve had received preceding pulmonary artery banding. A two-patch repair was employed in all cases. The patients' median age and weight were 4.5 (1.2-48) months and 4.7 (2.5-12.5) kg, respectively. The mean stays in the intensive care unit and in the hospital were 5.3+/-3.8 and 25.4+/-18.1 days, respectively. The median duration of mechanical ventilation was 11.6 h. There were two in-hospital deaths, in patients 5.2 and 5.9 months of age. Both had underlying Down's syndrome, and significant pulmonary vascular obstructive disease (PVOD) was detected on postmortem specimen. The operative outcome of CAVSD was generally satisfactory. PVOD can progress rapidly from four to five months, especially with Down's syndrome. Therefore, in order to avoid progression to irreversible PVOD, surgical intervention within four months of birth may be appropriate in such patients.

Entities:  

Mesh:

Year:  2006        PMID: 17669760     DOI: 10.1510/icvts.2006.134288

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  2 in total

1.  The Incidence of Cardiac Lesions among Children with Down's Syndrome in Jamaica - A Prospective Study.

Authors:  C Scott; M Thame
Journal:  West Indian Med J       Date:  2015-08-26       Impact factor: 0.171

2.  Prescription of cardiovascular medication in children with congenital heart defects across six European Regions from 2000 to 2014: data from the EUROlinkCAT population-based cohort study.

Authors:  Mads Damkjaer; Stine Kjaer Urhoj; Joachim Tan; Gillian Briggs; Maria Loane; Joanne Emma Given; Laia Barrachina-Bonet; Clara Cavero-Carbonell; Alessio Coi; Amanda J Neville; Anna Heino; Sonja Kiuru-Kuhlefelt; Susan Jordan; Ieuan Scanlon; Anna Pierini; Aurora Puccini; Ester Garne; Joan K Morris
Journal:  BMJ Open       Date:  2022-04-21       Impact factor: 3.006

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.